In our previous publication (30), therapeutic CTLA4-PD-L1 DNA cancer vaccines can reduce iCCA tumor growth in a rat thioacetamide (TAA)-induced iCCA model. The gene discussed is CTLA4; the disease is infantile convulsions and choreoathetosis.